Terms: = Sarcomas AND ASPSCR1, Q9BZE9, 79058, ENSG00000169696 AND Treatment
8 results:
1. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
[TBL] [Abstract] [Full Text] [Related]
2. Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.
Phadnis S; Wang X; Daw NC; Herzog CE; Subbiah IM; Zaky W; Gouda MA; Morani AC; Amini B; Harrison DJ; Piha-Paul SA; Meric-Bernstam F; Gorlick R; Schwartz CL; Subbiah V
ESMO Open; 2023 Dec; 8(6):101609. PubMed ID: 37879233
[TBL] [Abstract] [Full Text] [Related]
3. Advances in treatment of alveolar soft part sarcoma: an updated review.
Fujiwara T; Kunisada T; Nakata E; Nishida K; Yanai H; Nakamura T; Tanaka K; Ozaki T
Jpn J Clin Oncol; 2023 Nov; 53(11):1009-1018. PubMed ID: 37626447
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract] [Full Text] [Related]
5. Case Report: Two Cases of Soft-Tissue sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy.
Li Y; Liu Y; Qu Y; Chen X; Qu X; Ye Y; Du X; Cheng Y; Xu M; Zhang H
Front Immunol; 2022; 13():832593. PubMed ID: 35603147
[TBL] [Abstract] [Full Text] [Related]
6. Future directions in soft tissue sarcoma treatment.
Hall F; Villalobos V; Wilky B
Curr Probl Cancer; 2019 Aug; 43(4):300-307. PubMed ID: 31229264
[TBL] [Abstract] [Full Text] [Related]
7. Diagnosis, Prognosis, and treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract] [Full Text] [Related]
8. Xp11 Translocation Renal Cell Carcinoma and the Mesenchymal Counterparts: An Evolving Concept with Novel Insights on Clinicopathologic Features, Prognosis, treatment, and Classification.
Wang XT; Xia QY; Zhou XJ; Rao Q
Crit Rev Oncog; 2017; 22(5-6):481-497. PubMed ID: 29604926
[TBL] [Abstract] [Full Text] [Related]